TP53 and metastatic neoplasm: Among them, p53 has been tested in several trials for HCC (NCT00003147, NCT02561546, NCT02509169, NCT02418988, and NCT02432963), as well as p53 gene vaccination for other liver tumors, including metastatic tumors from other organs (NCT02432963).